UNSPSC 85893637: High dose rate (hdr) brachytherapy of urethra using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of urethra using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DT139BZ

UNSPSC 85893637 High dose rate (hdr) brachytherapy of urethra using palladium 103 (pd-103) is a Commodity code that appears to describe a specialized oncology treatment modality, but the recent state and local solicitation activity tagged under this code does not reflect that scope. The single recent opportunity shows no relevant activity; the County of Santa Clara Health System's July 7, 2026 RFQ for temporary health professional staffing services across ancillary clinical categories (Audiology, Radiology, Gastroenterology, Respiratory Care, Surgical Services, Therapy Services, and others) is a staffing and labor procurement unrelated to brachytherapy equipment, supplies, or treatment planning. The mismatch suggests either a classification error in the state or local procurement system or a broad tagging artifact that does not reflect actual buying intent under this code.

No meaningful recent opportunities under UNSPSC 85893637 support a pursue-or-watch assessment for brachytherapy-related services or products. If your firm competes in oncology treatment services or related medical devices, verify the correct UNSPSC code through direct engagement with the issuing body or state procurement office before responding to opportunities tagged under this code.